P22102 (PUR2_HUMAN) Homo sapiens (Human)

Trifunctional purine biosynthetic protein adenosine-3 UniProtKBAFDB90v4InterProSTRINGInteractive Modelling

1010 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

40 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Human aminoimidazole ribonucleotide synthetase
2v9y
homo-2-mer475-792
2×SO4;
Assess
Human GAR transformylase in complex with GAR substrate and AGF102 inhibitor
7jg0
homo-2-mer808-1007
2×GAR; 2×V97;
Assess
Human glycinamide ribonucleotide synthetase
2qk4
monomer1-429
1×CL; 1×SO4; 1×ATP; 2×GOL;
Assess
The structure of human glycinamide ribonucleotide transformylase in complex with 10S-methylthio-DDA…
4ew2
monomer808-1010
1×PO4; 2×SO4; 1×DXY;
Assess
The structure of human glycinamide ribonucleotide transformylase in complex with 10R-methylthio-DDA…
4ew3
monomer808-1010
1×PO4; 2×SO4; 1×DXZ;
Assess
human glycinamide ribonucleotide Transformylase at pH 4.2
1meo
monomer808-1010
1×PO4; 1×SO4;
Assess
High resolution structure of human glycinamide ribonucleotide transformylase in apo form.
4ew1
monomer810-1010
1×PO4; 3×SO4;
Assess
Human GAR transformylase in complex with GAR and N-({5-[(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d…
4zyv
monomer808-1008
1×GAR; 1×G71;
Assess
HUMAN GAR TRANSFORMYLASE IN COMPLEX WITH GAR AND (S)-2-({4-[3-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO…
4zz1
monomer808-1007
1×GAR; 1×3YF;
Assess
HUMAN GAR TRANSFORMYLASE IN COMPLEX WITH GAR AND (S)-2-({5-[3-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO…
4zz2
monomer808-1007
1×GAR; 1×3YG;
Assess
Human GAR transformylase in complex with GAR and (S)-2-(7-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3…
4zyz
monomer808-1007
1×GAR; 1×3YD;
Assess
Human GAR transformylase in complex with GAR and (S)-2-({4-[4-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo…
4zyx
monomer808-1007
1×GAR; 1×3YB;
Assess
Human GAR transformylase in complex with GAR and (S)-2-(8-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3…
4zz0
monomer808-1007
1×GAR; 1×3YE;
Assess
Human GAR transformylase in complex with GAR and N-{4-[4-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-…
4zyt
monomer808-1007
1×GAR; 1×3Y9;
Assess
Human GAR transformylase in complex with GAR and (S)-2-({5-[4-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo…
4zyy
monomer808-1007
1×GAR; 1×3YC;
Assess
Human GAR transformylase in complex with GAR and N-{4-[4-(2-Amino-4-oxo-3,4-dihydrothieno[2,3-d]pyr…
4zyu
monomer808-1007
1×GAR; 1×3YA;
Assess
human GAR Tfase in complex with hydrolyzed form of 10-trifluoroacetyl-5,10-dideaza-acyclic-5,6,7,8-…
1njs
monomer808-1007
2×PO4; 1×KEU;
Assess
Human GAR Tfase complex structure with polyglutamated 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,…
1rc0
monomer808-1007
1×KT5;
Assess
Human GAR transformylase in complex with GAR and N-({5-[(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d…
4zyw
monomer808-1007
1×GAR; 1×G94;
Assess
Human GAR transformylase in complex with GAR substrate and AGF132 inhibitor
8fdy
monomer808-1007
1×GAR; 1×XSI;
Assess
The structure of human glycinamide ribonucleotide transformylase in complex with alpha,beta-N-(hydr…
1zly
monomer808-1007
1×GRF; 1×DQB;
Assess
AGF271 and GAR in complex with human recombinant GARFTase, ligase, purine biosynthesis, transfers f…
8fdx
monomer808-1007
1×GAR; 1×XRR;
Assess
Human GAR transformylase in complex with GAR substrate and AGF347 inhibitor
8fjw
monomer808-1007
1×GAR; 1×Y79;
Assess
Human GAR transformylase in complex with GAR substrate and AGF103 inhibitor
7jg3
monomer808-1007
1×GAR; 1×V9A; 1×NA;
Assess
Human GAR transformylase in complex with GAR and (4-{[2-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d…
5j9f
monomer808-1007
1×GAR; 1×83A;
Assess
Human GAR Tfase complex structure with polyglutamated 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,…
1rbz
monomer808-1007
1×KT5;
Assess
Human GAR Tfase complex structure with 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrof…
1rby
monomer808-1007
1×KEU; 1×GAR;
Assess
Human GAR Tfase complex structure with 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrof…
1rbq
monomer808-1007
2×PO4; 1×KEU;
Assess
Human GAR transformylase in complex with GAR substrate and AGF320 inhibitor
8fjx
monomer808-1007
1×Y7L; 1×GAR;
Assess
The apo structure of human glycinamide ribonucleotide transformylase
1zlx
monomer808-1007
1×GOL;
Assess
Human GAR transformylase in complex with GAR substrate and AGF305 inhibitor
8fe0
monomer808-1007
1×GAR; 1×XSO;
Assess
Human GAR Tfase complex structure with polyglutamated 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,…
1rc1
monomer808-1007
1×PO4; 1×KT3;
Assess
Human GAR Tfase complex structure with polyglutamated 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,…
1rbm
monomer808-1007
2×PO4; 1×KT5;
Assess
Human GAR transformylase in complex with GAR substrate and AGF131 inhibitor
7jg4
monomer808-1007
1×GAR; 1×V9V; 1×NA;
Assess
Human GAR transformylase in complex with GAR substrate and AGF302 inhibitor
8fdz
monomer808-1007
1×GAR; 1×XSO;
Assess
Human GAR transformylase in complex with GAR and pemetrexed
4zz3
monomer808-1007
1×4DW; 1×GAR;
Assess
Human GAR transformylase in complex with GAR substrate and AGF362 inhibitor
8fjv
monomer808-1007
1×GAR; 1×Y72;
Assess
Human GAR transformylase in complex with GAR substrate and AGF291 inhibitor
8fjy
monomer808-1007
1×GAR; 1×Y6U;
Assess
Human Glycinamide Ribonucleotide Transformylase domain at pH 8.5
1mej
monomer810-1007
1×PO4;
Assess
complex structure of human GAR Tfase and substrate beta-GAR
1men
monomer810-1007
1×GAR;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2qk4.1.Amonomer0.891-428
1×ATP;99.77
Assess
1cli.3.Amonomer0.72433-778
47.95
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 22qk4.1.Amonomer0.931-429
1×ATP;99.77
Assess